Biotech Co. Sues Sandoz Over Remodulin Generic – site.law360.com

March 15, 2012 Posted By: Leave a comment
The Maryland-based biotechnology company brought its complaint after Sandoz sought federal approval of an abbreviated new drug application to make and sell a generic version of Remodulin throughout the U.S. before the expiration of United Therapeutics ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>